• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Cell Therapy Market Share

    ID: MRFR/LS/3630-CR
    95 Pages
    Kinjoll Dey
    February 2021

    Cell Therapy Market Research Report By Application (Oncology, Cardiovascular Disease, Neurological Disorders, Orthopedic Disorders), By Type (Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy), By Delivery Method (Intravenous Injection, Subcutaneous Injection, Intradermal Injection, Intramuscular Injection), By End User (Hospitals, Research Institutions, Ambulatory Surgical Ce...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Cell Therapy Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Share

    Cell Therapy Market Share Analysis

    The cell therapy market has witnessed striking growth in recent years, driven by advancements in biotechnology and a creating spotlight on customized medication. As the competition intensifies, organizations are adopting different market share positioning strategies to gain a competitive advantage. Organizations in the cell therapy market are strategically upgrading their therapeutic applications. By developing their product portfolios to cover numerous diseases, including cancer, cardiovascular issues, and autoimmune conditions, they aim to capture a greater market share. This approach permits organizations to cater to different patient necessities and establish themselves as central individuals in multiple therapeutic districts. Achieving scalability in cell therapy manufacturing is a critical aspect of market positioning. Organizations are investing in innovative manufacturing technologies and cycle optimization to update production capability and decrease costs. Scalability guarantees a strong and cost-effective store network, enabling organizations to meet the rising interest for cell therapies. Seeing the importance of patient access, organizations are implementing projects to make cell therapies more open and practical. These initiatives incorporate collaborations with healthcare providers, payers, and government bodies to guarantee greater patient reach. Further creating affordability redesigns market penetration and strengthens an organization's position as a socially cautious player in the industry. Effective marketing and checking strategies are vital for creating care and establishing a strong market presence. Organizations are investing in targeted marketing campaigns, educational initiatives, and stamping efforts to differentiate their products and collect trust among healthcare experts, patients, and stakeholders. In the rapidly creating scene of cell therapy, organizations hurry to adopt technological advancements. This incorporates incorporating artificial intelligence, AI, and other cutting-edge technologies into examination, development, and manufacturing processes. Staying at the forefront of technological innovation works on an organization's competitiveness and positions it as a precursor in the field.

    Market Summary

    As per Market Research Future Analysis, the Cell Therapy Market was valued at 16.14 USD Billion in 2024 and is projected to reach 39.92 USD Billion by 2035, driven by the rising incidence of chronic diseases and advancements in biotechnology. The market is characterized by a focus on personalized medicine and regenerative therapies, with significant investments in research and development.

    Key Market Trends & Highlights

    Key trends driving the Cell Therapy Market include advancements in technology and increasing demand for innovative treatments.

    • The Cell Therapy Market is expected to grow from 14.82 USD Billion in 2024 to 42.3 USD Billion by 2035. Oncology applications are projected to grow from 6.5 USD Billion in 2024 to 18.5 USD Billion by 2035. North America is expected to dominate the market, growing from 6.9 USD Billion in 2024 to 19.9 USD Billion by 2035. Over 80 cell therapy products have received market approval or are under investigation, indicating a supportive regulatory environment.

    Market Size & Forecast

    2024 Market Size USD 16.14 Billion
    2035 Market Size USD 39.92 Billion
    CAGR (2025-2035) 8.58%
    Largest Regional Market Share in 2024 North America.

    Major Players

    <p>Key players in the Cell Therapy Market include Bluebird Bio, Adaptimmune, Gilead Sciences, Kite Pharma, and Novartis.</p>

    Market Trends

    The rising incidence of chronic illnesses and developments in biotechnology are two major drivers propelling the cell therapy market. The need for novel treatments that might provide more efficient and focused therapy is being driven by the increasing prevalence of diseases like cancer, diabetes, and heart disease.

    Additionally, novel cell-based medicines are being discovered as a result of increased research and development investments, improving the available therapy options. To speed up the development of cell therapy, opportunities for partnerships between academic institutions, research centers, and pharmaceutical corporations are also being investigated.

    In addition to encouraging creativity, this synergy makes it easier to provide more efficient treatment options for people all around the world. As stakeholders see the possibility of customizing therapies to meet the needs of each patient, recent developments show that the cell therapy industry is increasingly focused on personalized medicine.

    Furthermore, regenerative medicine—in particular, stem cell therapies—is becoming more and more popular as prospective treatments for a range of illnesses. In response to these advancements, regulatory agencies around the world are also streamlining the approval procedures for cell therapy products. This creates a more favorable atmosphere for introducing innovative treatments to the market.

    Furthermore, cell therapies are becoming more widely available to patients due to the trend toward outpatient care and home-based treatments. The market for cell therapy is expected to continue expanding as the healthcare industry changes, driven by these new developments.

     

    <p>The Global Cell Therapy Market is poised for transformative growth, driven by advancements in regenerative medicine and increasing clinical applications across various therapeutic areas.</p>

    U.S. National Institutes of Health (NIH)

    Cell Therapy Market Market Drivers

    Market Trends and Projections

    The Global Cell Therapy Market Industry is characterized by dynamic trends and projections that reflect its growth potential. Current estimates suggest that the market will reach 30 USD Billion in 2024, with a significant increase to 75 USD Billion anticipated by 2035. This growth trajectory indicates a compound annual growth rate of 8.69 percent from 2025 to 2035. The market is evolving rapidly, driven by factors such as technological advancements, regulatory support, and increasing investment in research and development. These trends highlight the promising future of cell therapies as a cornerstone of modern medicine.

    Supportive Regulatory Frameworks

    The Global Cell Therapy Market Industry benefits from supportive regulatory frameworks that facilitate the approval and commercialization of innovative therapies. Regulatory bodies, such as the U.S. Food and Drug Administration and the European Medicines Agency, are increasingly streamlining the approval processes for cell-based therapies. This proactive approach encourages investment and research in the field, fostering a conducive environment for innovation. As a result, the market is poised for growth, with a projected compound annual growth rate of 8.69 percent from 2025 to 2035. Such regulatory support is crucial for accelerating the development and accessibility of cell therapies to patients worldwide.

    Advancements in Regenerative Medicine

    Technological advancements in regenerative medicine are significantly influencing the Global Cell Therapy Market Industry. Innovations in stem cell research and gene editing techniques, such as CRISPR, are enhancing the efficacy and safety of cell therapies. These advancements enable the development of personalized treatment options, which are increasingly favored by healthcare providers and patients alike. As a result, the market is expected to grow substantially, with projections indicating a rise to 75 USD Billion by 2035. This growth trajectory suggests that regenerative medicine will play a pivotal role in shaping the future of healthcare, particularly in the treatment of previously incurable conditions.

    Rising Prevalence of Chronic Diseases

    The Global Cell Therapy Market Industry is experiencing growth due to the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders. These conditions necessitate innovative treatment options, leading to a surge in demand for cell therapies. For instance, the World Health Organization reports that chronic diseases account for approximately 71 percent of all deaths globally. This alarming statistic underscores the urgent need for effective therapies, positioning cell therapy as a promising solution. As the industry evolves, it is projected to reach a valuation of 30 USD Billion in 2024, reflecting the critical role of cell therapies in addressing these health challenges.

    Increasing Investment in Research and Development

    Investment in research and development is a key driver of the Global Cell Therapy Market Industry. Pharmaceutical companies and biotechnology firms are allocating substantial resources to explore novel cell-based therapies. This trend is evidenced by the increasing number of clinical trials and collaborations between academic institutions and industry players. The commitment to R&D is expected to yield breakthroughs that enhance the effectiveness of existing therapies and introduce new treatment modalities. Consequently, this influx of investment is likely to contribute to the market's growth, with projections indicating a valuation of 30 USD Billion by 2024, highlighting the industry's potential.

    Growing Awareness and Acceptance of Cell Therapies

    The Global Cell Therapy Market Industry is witnessing a surge in awareness and acceptance of cell therapies among healthcare professionals and patients. Educational initiatives and successful case studies are helping to demystify these innovative treatments, leading to increased demand. As patients become more informed about the potential benefits of cell therapies, healthcare providers are more inclined to incorporate these options into treatment plans. This growing acceptance is expected to drive market growth, with projections indicating a compound annual growth rate of 8.69 percent from 2025 to 2035. The shift in perception is crucial for the broader adoption of cell therapies in clinical practice.

    Market Segment Insights

    Cell Therapy Market Application Insights

    <p>The Cell Therapy Market demonstrated a significant expansion in applications across various health conditions, with the oncology segment leading the way.</p>

    <p>In 2024, the oncology application alone was valued at 6.5 USD Billion, and it is projected to grow to 18.5 USD Billion by 2035, underscoring its majority holding within the market. This dominance was attributed to the increasing incidence of cancer and ongoing advancements in targeted therapies and immunotherapies that leverage cell-based innovations.</p>

    <p>Following oncology, cardiovascular disease was another crucial segment with a valuation of 3.8 USD Billion in 2024, anticipated to reach 10.8 USD Billion by 2035. The rising prevalence of heart-related ailments and the aging population contributed to the importance of developing effective cell therapies for cardiovascular treatment.</p>

    Cell Therapy Market Type Insights

    <p>The dynamic industry is characterized by diverse types of therapies which include Autologous Cell Therapy, Allogeneic Cell Therapy, and Stem Cell Therapy. Autologous Cell Therapy stands out due to its use of a patient's own cells, which enhances treatment compatibility and minimizes the risk of rejection, making it a significant option in regenerative medicine.</p>

    <p>In contrast, Allogeneic Cell Therapy leverages cells from donors, providing a scalable solution for treating various conditions such as cancers and genetic disorders. Stem Cell Therapy represents another crucial aspect, with its potential to differentiate into multiple cell types, offering transformative possibilities for chronic diseases and tissue repair.</p>

    <p>The Cell Therapy Market data indicates that the market's growth is driven by increasing incidences of chronic diseases and advancements in clinical applications, though it faces challenges like high development costs and regulatory hurdles.</p>

    Cell Therapy Market Delivery Method Insights

    <p>The Cell Therapy Market has observed notable advancements in its Delivery Method segment, which plays a crucial role in the successful administration of therapeutic treatments. Among the various methods employed, Intravenous Injection is prominent due to its efficiency and rapid absorption rates, making it a preferred choice for systemic treatments.</p>

    <p>Subcutaneous Injection also holds significance as it provides a less invasive alternative, enabling patients to self-administer therapy, which enhances patient adherence. Similarly, Intradermal Injection is increasingly recognized for its applications in localized immunotherapy treatments.</p>

    <p>Intramuscular Injection is vital in administering certain types of cell therapies, particularly where robust immune responses are desired. As the market evolves, factors such as an aging population, rising prevalence of chronic diseases, and ongoing Research and Development initiatives are driving market growth.</p>

    Cell Therapy Market End User Insights 

    <p>The Cell Therapy Market, particularly focused on the End User segment, shows a robust landscape which is integral to patient care and scientific advancement. Hospitals emerge as leading venues for cell therapy applications, owing to their extensive resources and patient reach. Research Institutions are vital for innovating new therapies, driving pivotal research and development that underpins the industry.</p>

    <p>Additionally, Ambulatory Surgical Centers facilitate outpatient cell therapies, proving advantageous for patient convenience and cost-effectiveness. This diversification in End Users not only enhances market growth but also aligns with the trend towards personalized medicine.</p>

    <p>The shift towards regenerative treatments highlights the importance of these venues in improving patient outcomes while addressing the need for effective healthcare solutions. Enhanced funding and technological advances are expected to further invigorate these sectors, driving their importance in the Cell Therapy Market revenue and statistics moving forward.</p>

    Get more detailed insights about Cell Therapy Market Research Report - Global Forecast till 2035

    Regional Insights

    The Cell Therapy Market revenue was poised for substantial growth. The Regional segmentation highlighted North America as a dominant player, held a valuation of 6.9 USD Billion in 2024, increasing significantly to 19.9 USD Billion by 2035, driven by advancements in Research and Development and robust healthcare infrastructure.

    Europe followed closely, valued at 4.3 USD Billion in 2024, reflecting a strong emphasis on innovative therapies and increasing regulatory support, which is expected to rise to 12.4 USD Billion by 2035.

    The APAC region, with a valuation of 2.8 USD Billion in 2024, showcased a growing interest in cell therapies attributed to increasing investments in healthcare and burgeoning biotechnology sectors, expected to expand to 8.4 USD Billion by 2035.

    Meanwhile, South America and MEA, with values of 0.8 USD Billion and 0.9 USD Billion respectively in 2024, exhibited potential for growth due to improving access to healthcare services, projected to reach 2.4 USD Billion and 2.7 USD Billion by 2035.

    Overall, the Cell Therapy Market segmentation depicted a diverse landscape with North America holding the majority share, driven by technological advancements and increased funding for cell-based therapies.

    Cell Therapy Market Regional

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Cell Therapy Market has emerged as a dynamic and rapidly evolving sector within the broader healthcare landscape, driven by unprecedented advancements in biotechnology and regenerative medicine. This market includes a variety of therapies that utilize human cells to treat diseases, particularly cancer, genetic disorders, and autoimmune diseases.

    The competitive landscape is characterized by a blend of established pharmaceutical companies and innovative biotechnology firms, each vying for market share through strategic partnerships, research collaborations, product development, and regulatory approvals.

    The drive for innovative therapies has resulted in significant investments in research and development, as well as a surge in clinical trials aimed at refining cell therapy techniques. With robust funding and a growing pipeline of novel therapies, companies are racing to differentiate their offerings in a competitive market characterized by rapid technological advancements and shifting regulatory landscapes.

    Bluebird Bio has made significant strides in the Cell Therapy Market, particularly in the development of innovative treatments for genetic disorders and various types of cancers. The company has established a strong reputation for its pioneering work in gene therapy, leveraging cutting-edge technologies such as lentiviral vector delivery systems.

    One of the key strengths of Bluebird Bio lies in its robust pipeline, which includes multiple clinical-stage programs aimed at treating severe genetic diseases and hematological malignancies. Furthermore, the company has cultivated strategic partnerships and collaborations that enhance its research capabilities and expedite product development.

    Their comprehensive approach, focusing on both clinical efficacy and safety, has positioned Bluebird Bio as a formidable player in the cell therapy space, enabling it to capture a meaningful share of the market.

    Adaptimmune is recognized for its innovative approach to cell therapy, particularly in developing T-cell receptor (TCR) therapies aimed at targeting cancer. The company has a solid market presence with a focus on advancing its unique proprietary platform that allows the engineering of T cells to recognize and attack cancer cells effectively.

    Adaptimmune's strengths lie in its well-defined pipeline of product candidates, which are undergoing investigations for various cancer types, showcasing the potential for significant therapeutic breakthroughs.

    The company has strategically pursued mergers and acquisitions to bolster its research capabilities and expand its operational footprint globally. With a dedicated team of experts and strong commitments to clinical trials, Adaptimmune is well-positioned to capitalize on emerging opportunities within the Cell Therapy Market, aiming to deliver transformative treatment options for patients worldwide.

    Key Companies in the Cell Therapy Market market include

    Industry Developments

    Recent developments in the Cell Therapy Market indicate a growing emphasis on innovative treatments for chronic diseases and cancers. Notable companies such as Bluebird Bio, Adaptimmune, and Gilead Sciences have been focusing on expanding their Research and Development efforts to harness advanced cellular technologies.

    In October 2023, Adaptimmune reported promising early results from its T-cell therapy trials targeted at solid tumors, enhancing investor interest in the sector. In terms of mergers and acquisitions, Kite Pharma, a subsidiary of Gilead Sciences, announced an acquisition of TCR2 Therapeutics in September 2023, aimed at bolstering its cell therapy portfolio.

    The market valuation for cell therapies is projected to reach new heights, driven by increasing approval rates from regulatory agencies and the growing acceptance of personalized medicine. AstraZeneca’s advancements in CAR-T therapies have also contributed to shifting the market dynamics.

    Over the past years, the continued integration of technology in cell therapies has seen significant progress, with Novartis leading novel T-cell therapies towards commercialization. Collectively, these developments demonstrate a robust upward trajectory tailored to meet the increasing demand for effective therapeutic solutions in the healthcare landscape.

    Future Outlook

    Cell Therapy Market Future Outlook

    <p>The Global Cell Therapy Market is projected to grow at an 8.58% CAGR from 2025 to 2035, driven by technological advancements, increasing investments, and rising prevalence of chronic diseases.</p>

    New opportunities lie in:

    • <p>Develop personalized cell therapies targeting specific genetic disorders. Invest in automation technologies for scalable cell manufacturing processes. Expand partnerships with biotech firms to enhance research and development capabilities.</p>

    <p>By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in innovative therapeutic solutions.</p>

    Market Segmentation

    Cell Therapy Market Type Outlook

    • Autologous Cell Therapy
    • Allogeneic Cell Therapy
    • Stem Cell Therapy

    Cell Therapy Market End User Outlook

    • Hospitals
    • Research Institutions
    • Ambulatory Surgical Centers

    Cell Therapy Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Cell Therapy Market Application Outlook

    • Oncology
    • Cardiovascular Disease
    • Neurological Disorders
    • Orthopedic Disorders

    Cell Therapy Market Delivery Method Outlook

    • Intravenous Injection
    • Subcutaneous Injection
    • Intradermal Injection
    • Intramuscular Injection

    Report Scope

    Report Attribute/Metric Source:Details
    MARKET SIZE 202313.47(USD Billion)
    MARKET SIZE 202416.14(USD Billion)
    MARKET SIZE 203539.92(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)8.58% (2025 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    MARKET FORECAST PERIOD2025 - 2035
    HISTORICAL DATA2019 - 2023
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDBluebird Bio, Adaptimmune, Gilead Sciences, Celyad, Kite Pharma, Sangamo Therapeutics, Allogene Therapeutics, TCR2 Therapeutics, Celgene, Novartis, Fate Therapeutics, BristolMyers Squibb, AstraZeneca, Amgen, Juno Therapeutics
    SEGMENTS COVEREDApplication, Type, Delivery Method, End User, Regional
    KEY MARKET OPPORTUNITIESIncreased investment in R&D, Expansion in regenerative medicine, Collaborations and partnerships growth, Rising demand for personalized therapies, Advancements in manufacturing technologies
    KEY MARKET DYNAMICSIncreasing prevalence of chronic diseases, Advancements in regenerative medicine, Favorable government regulations, Growing investment in research, Rising awareness of cell therapies
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    Market Size 202416.14
    Market Size 202517.53
    Market Size 203539.92
    Base Year2024
    Market Forecast Period2025 - 2035

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What is the projected growth of the Cell Therapy market?

    The Cell Therapy market is the expected increase in total market value of 39.92 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Cell Therapy market?

    Cell Therapy market size was valued at approximately 16.14 billion USD in 2024. This figure will reach 39.92 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Cell Therapy market?

    Cell Therapy market is expected to grow at a CAGR of 8.58% between 2025 and 2035.

    How much will the Cell Therapy market be worth by 2035?

    Cell Therapy market is expected to be worth of 39.92 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Cell Therapy market perform over the next 10 years?

    Over the next 10 years the Cell Therapy market is expected to shift from usd billion 16.14 to 39.92 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    What will be the market size of the Global Cell Therapy Market by 2035?

    By 2035, the Global Cell Therapy Market is anticipated to reach a value of 42.3 USD Billion.

    Which application holds the largest market share in the Global Cell Therapy Market in 2024?

    In 2024, the Oncology application holds the largest market share at 6.5 USD Billion.

    What will be the market value of the Cardiovascular Disease segment in 2035?

    The market value of the Cardiovascular Disease segment is projected to be 10.8 USD Billion in 2035.

    Which region will dominate the Global Cell Therapy Market by 2035?

    North America is expected to dominate the Global Cell Therapy Market with a value of 19.9 USD Billion by 2035.

    Who are the key players in the Global Cell Therapy Market?

    Key players in the Global Cell Therapy Market include Bluebird Bio, Gilead Sciences, Kite Pharma, and Novartis.

    1. --- "
    2. Table of Contents
    3. EXECUTIVE SUMMARY
    4. Market Overview
    5. Key Findings
    6. Market Segmentation
    7. Competitive Landscape
    8. Challenges and Opportunities
    9. Future Outlook
    10. MARKET INTRODUCTION
    11. Definition
    12. Scope of the study
    13. Research Objective
    14. Assumption
    15. Limitations
    16. RESEARCH METHODOLOGY
    17. Overview
    18. Data Mining
    19. Secondary Research
    20. Primary Research
    21. Primary Interviews and Information Gathering Process
    22. Breakdown of Primary Respondents
    23. Forecasting Model
    24. Market Size Estimation
    25. Bottom-Up Approach
    26. Top-Down Approach
    27. Data Triangulation
    28. Validation
    29. MARKET DYNAMICS
    30. Overview
    31. Drivers
    32. Restraints
    33. Opportunities
    34. MARKET FACTOR ANALYSIS
    35. Value chain Analysis
    36. Porter's Five Forces Analysis
    37. Bargaining Power of Suppliers
    38. Bargaining Power of Buyers
    39. Threat of New Entrants
    40. Threat of Substitutes
    41. Intensity of Rivalry
    42. COVID-19 Impact Analysis
    43. Market Impact Analysis
    44. Regional Impact
    45. Opportunity and Threat Analysis
    46. Cell Therapy Market, BY Application (USD Billion)
    47. Oncology
    48. Cardiovascular Disease
    49. Neurological Disorders
    50. Orthopedic Disorders
    51. Cell Therapy Market, BY Type (USD Billion)
    52. Autologous Cell Therapy
    53. Allogeneic Cell Therapy
    54. Stem Cell Therapy
    55. Cell Therapy Market, BY Delivery Method (USD Billion)
    56. Intravenous Injection
    57. Subcutaneous Injection
    58. Intradermal Injection
    59. Intramuscular Injection
    60. Cell Therapy Market, BY End User (USD Billion)
    61. Hospitals
    62. Research Institutions
    63. Ambulatory Surgical Centers
    64. Cell Therapy Market, BY Regional (USD Billion)
    65. North America
    66. US
    67. Canada
    68. Europe
    69. Germany
    70. UK
    71. France
    72. Russia
    73. Italy
    74. Spain
    75. Rest of Europe
    76. APAC
    77. China
    78. India
    79. Japan
    80. South Korea
    81. Malaysia
    82. Thailand
    83. Indonesia
    84. Rest of APAC
    85. South America
    86. Brazil
    87. Mexico
    88. Argentina
    89. Rest of South America
    90. MEA
    91. GCC Countries
    92. South Africa
    93. Rest of MEA
    94. Competitive Landscape
    95. Overview
    96. Competitive Analysis
    97. Market share Analysis
    98. Major Growth Strategy in the Cell Therapy Market
    99. Competitive Benchmarking
    100. Leading Players in Terms of Number of Developments in the Cell Therapy Market
    101. Key developments and growth strategies
    102. New Product Launch/Service Deployment
    103. Merger & Acquisitions
    104. Joint Ventures
    105. Major Players Financial Matrix
    106. Sales and Operating Income
    107. Major Players R&D Expenditure. 2023
    108. Company Profiles
    109. Bluebird Bio
    110. Financial Overview
    111. Products Offered
    112. Key Developments
    113. SWOT Analysis
    114. Key Strategies
    115. Adaptimmune
    116. Financial Overview
    117. Products Offered
    118. Key Developments
    119. SWOT Analysis
    120. Key Strategies
    121. Gilead Sciences
    122. Financial Overview
    123. Products Offered
    124. Key Developments
    125. SWOT Analysis
    126. Key Strategies
    127. Celyad
    128. Financial Overview
    129. Products Offered
    130. Key Developments
    131. SWOT Analysis
    132. Key Strategies
    133. Kite Pharma
    134. Financial Overview
    135. Products Offered
    136. Key Developments
    137. SWOT Analysis
    138. Key Strategies
    139. Sangamo Therapeutics
    140. Financial Overview
    141. Products Offered
    142. Key Developments
    143. SWOT Analysis
    144. Key Strategies
    145. Allogene Therapeutics
    146. Financial Overview
    147. Products Offered
    148. Key Developments
    149. SWOT Analysis
    150. Key Strategies
    151. TCR2 Therapeutics
    152. Financial Overview
    153. Products Offered
    154. Key Developments
    155. SWOT Analysis
    156. Key Strategies
    157. Celgene
    158. Financial Overview
    159. Products Offered
    160. Key Developments
    161. SWOT Analysis
    162. Key Strategies
    163. Novartis
    164. Financial Overview
    165. Products Offered
    166. Key Developments
    167. SWOT Analysis
    168. Key Strategies
    169. Fate Therapeutics
    170. Financial Overview
    171. Products Offered
    172. Key Developments
    173. SWOT Analysis
    174. Key Strategies
    175. BristolMyers Squibb
    176. Financial Overview
    177. Products Offered
    178. Key Developments
    179. SWOT Analysis
    180. Key Strategies
    181. AstraZeneca
    182. Financial Overview
    183. Products Offered
    184. Key Developments
    185. SWOT Analysis
    186. Key Strategies
    187. Amgen
    188. Financial Overview
    189. Products Offered
    190. Key Developments
    191. SWOT Analysis
    192. Key Strategies
    193. Juno Therapeutics
    194. Financial Overview
    195. Products Offered
    196. Key Developments
    197. SWOT Analysis
    198. Key Strategies
    199. Appendix
    200. References
    201. Related Reports

    Cell Therapy Market Segmentation

     

     

     

    Cell Therapy Market By Application (USD Billion, 2019-2035)

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

     

    Cell Therapy Market By Type (USD Billion, 2019-2035)

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

     

    Cell Therapy Market By Delivery Method (USD Billion, 2019-2035)

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

     

    Cell Therapy Market By End User (USD Billion, 2019-2035)

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

     

    Cell Therapy Market By Regional (USD Billion, 2019-2035)

    North America

    Europe

    South America

    Asia Pacific

    Middle East and Africa

     

    Cell Therapy Market Regional Outlook (USD Billion, 2019-2035)

     

     

    North America Outlook (USD Billion, 2019-2035)

    North America Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    North America Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    North America Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    North America Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    North America Cell Therapy Market by Regional Type

    US

    Canada

    US Outlook (USD Billion, 2019-2035)

    US Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    US Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    US Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    US Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    CANADA Outlook (USD Billion, 2019-2035)

    CANADA Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    CANADA Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    CANADA Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    CANADA Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    Europe Outlook (USD Billion, 2019-2035)

    Europe Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    Europe Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    Europe Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    Europe Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    Europe Cell Therapy Market by Regional Type

    Germany

    UK

    France

    Russia

    Italy

    Spain

    Rest of Europe

    GERMANY Outlook (USD Billion, 2019-2035)

    GERMANY Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    GERMANY Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    GERMANY Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    GERMANY Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    UK Outlook (USD Billion, 2019-2035)

    UK Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    UK Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    UK Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    UK Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    FRANCE Outlook (USD Billion, 2019-2035)

    FRANCE Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    FRANCE Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    FRANCE Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    FRANCE Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    RUSSIA Outlook (USD Billion, 2019-2035)

    RUSSIA Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    RUSSIA Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    RUSSIA Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    RUSSIA Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    ITALY Outlook (USD Billion, 2019-2035)

    ITALY Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    ITALY Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    ITALY Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    ITALY Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    SPAIN Outlook (USD Billion, 2019-2035)

    SPAIN Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    SPAIN Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    SPAIN Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    SPAIN Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    REST OF EUROPE Outlook (USD Billion, 2019-2035)

    REST OF EUROPE Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    REST OF EUROPE Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    REST OF EUROPE Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    REST OF EUROPE Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    APAC Outlook (USD Billion, 2019-2035)

    APAC Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    APAC Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    APAC Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    APAC Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    APAC Cell Therapy Market by Regional Type

    China

    India

    Japan

    South Korea

    Malaysia

    Thailand

    Indonesia

    Rest of APAC

    CHINA Outlook (USD Billion, 2019-2035)

    CHINA Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    CHINA Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    CHINA Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    CHINA Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    INDIA Outlook (USD Billion, 2019-2035)

    INDIA Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    INDIA Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    INDIA Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    INDIA Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    JAPAN Outlook (USD Billion, 2019-2035)

    JAPAN Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    JAPAN Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    JAPAN Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    JAPAN Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    SOUTH KOREA Outlook (USD Billion, 2019-2035)

    SOUTH KOREA Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    SOUTH KOREA Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    SOUTH KOREA Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    SOUTH KOREA Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    MALAYSIA Outlook (USD Billion, 2019-2035)

    MALAYSIA Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    MALAYSIA Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    MALAYSIA Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    MALAYSIA Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    THAILAND Outlook (USD Billion, 2019-2035)

    THAILAND Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    THAILAND Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    THAILAND Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    THAILAND Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    INDONESIA Outlook (USD Billion, 2019-2035)

    INDONESIA Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    INDONESIA Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    INDONESIA Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    INDONESIA Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    REST OF APAC Outlook (USD Billion, 2019-2035)

    REST OF APAC Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    REST OF APAC Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    REST OF APAC Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    REST OF APAC Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    South America Outlook (USD Billion, 2019-2035)

    South America Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    South America Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    South America Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    South America Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    South America Cell Therapy Market by Regional Type

    Brazil

    Mexico

    Argentina

    Rest of South America

    BRAZIL Outlook (USD Billion, 2019-2035)

    BRAZIL Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    BRAZIL Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    BRAZIL Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    BRAZIL Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    MEXICO Outlook (USD Billion, 2019-2035)

    MEXICO Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    MEXICO Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    MEXICO Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    MEXICO Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    ARGENTINA Outlook (USD Billion, 2019-2035)

    ARGENTINA Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    ARGENTINA Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    ARGENTINA Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    ARGENTINA Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)

    REST OF SOUTH AMERICA Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    REST OF SOUTH AMERICA Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    REST OF SOUTH AMERICA Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    REST OF SOUTH AMERICA Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    MEA Outlook (USD Billion, 2019-2035)

    MEA Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    MEA Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    MEA Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    MEA Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    MEA Cell Therapy Market by Regional Type

    GCC Countries

    South Africa

    Rest of MEA

    GCC COUNTRIES Outlook (USD Billion, 2019-2035)

    GCC COUNTRIES Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    GCC COUNTRIES Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    GCC COUNTRIES Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    GCC COUNTRIES Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    SOUTH AFRICA Outlook (USD Billion, 2019-2035)

    SOUTH AFRICA Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    SOUTH AFRICA Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    SOUTH AFRICA Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    SOUTH AFRICA Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

    REST OF MEA Outlook (USD Billion, 2019-2035)

    REST OF MEA Cell Therapy Market by Application Type

    Oncology

    Cardiovascular Disease

    Neurological Disorders

    Orthopedic Disorders

    REST OF MEA Cell Therapy Market by Type

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    REST OF MEA Cell Therapy Market by Delivery Method Type

    Intravenous Injection

    Subcutaneous Injection

    Intradermal Injection

    Intramuscular Injection

    REST OF MEA Cell Therapy Market by End User Type

    Hospitals

    Research Institutions

    Ambulatory Surgical Centers

     

     

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027